Tecentriq Hybreza (Atezolizumab and Hyaluronidase-Tqjs)

Active ingredients · Atezolizumab, Hyaluronidase (human Recombinant)

1875 mg/15mL / 30000 U/15mL · Injection

By Genentech, Inc.

Atezolizumab and Hyaluronidase-Tqjs · Injection · 1875 mg/15mL / 30000 U/15mL · Subcutaneous

NDC: 50242-0933
Route: Subcutaneous
Therapeutic class: Antibodies [CS], Antibodies, Monoclonal [CS], Antibodies, Monoclonal, Humanized [CS], Endoglycosidase , Glycoside Hydrolases [CS], Programmed Death Receptor-1 Blocking Antibody , Programmed Death Receptor-1-directed Antibody Interactions [MoA]
Marketing category: BLA

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a Quote

Request this medication.

Tell us the quantity you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs